H. pylori test and treat study for young adults
Part of Cancer, Digestive system clinical trials.
This study tests and treats young adults for H. pylori, a stomach bacteria, to see if treating it reduces future health risks. If you haven't been treated for H. pylori before, you may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 34 years old.
- You have never been treated for H. pylori infection before.
- You have not had part or all of your stomach removed (gastric resection).
- You can understand what the study involves and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether testing for an infection called H. pylori and using simple blood/screening tests (pepsinogen testing) can help prevent stomach cancer and reduce stomach-cancer-related deaths. You would be followed for health outcomes to see if the approach works better than standard care.
This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.
This trial tests a treatment combining a probiotic (Saccharomyces boulardii) with an antibiotic (minocycline) for people who have never been treated for H. pylori infection. It aims to see if this combination works well and is safe.
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
This study compares a treatment plan based on your genes to the standard treatment for H. pylori, a stomach infection that can cause ulcers. The goal is to see which approach works better and has fewer side effects.
This trial checks teenagers for a long-lasting H. pylori stomach infection and then treats those who need it. It may help prevent ongoing stomach problems from the infection and compare outcomes between treated and non-treated groups.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.